Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
70
Highlighting Progress in HIV, Ebola, Lassa, Zika and Cancer Vaccine Development   ATLANTA, GA, October 18, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
Last modified on Continue reading
90
ATLANTA, GA, October 15, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Latinx AIDS Awareness Day, a...
Last modified on Continue reading
1396
ATLANTA, GA, September 27, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Gay Men’s HIV/AIDS Awareness Day,...
Last modified on Continue reading
1479
ATLANTA, GA, September 26, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines, announced today that the U.S. Department of Defense...
Last modified on Continue reading
262
ATLANTA, GA, September 24, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today commented on recent age-associated HIV infection trends observed...
Last modified on Continue reading